Kabra Drugs P/B Ratio
Kabra Drugs P/B ratio. Kabra Drugs (KABRADG) P/B ratio is 1.56 (Moderate), book value per share ₹12.50 vs Healthcare average P/B of 0.01 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see KABRADG share price.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
KABRADG P/B Ratio — Valuation Insights & Book Value Analysis
Kabra Drugs price-to-book ratio interpretation, valuation status and historical context — current P/B 1.56 (Moderate). Analyse KABRADG shareholder distribution to track promoter, FII and institutional holdings.
- Current PB is 44.3% below historical average
- Trading at premium to sector average PB of 0.01
Kabra Drugs P/B Ratio Historical Trend
KABRADG annual price-to-book ratio — 3 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Kabra Drugs 52-week for the annual high/low range and current price position.
KABRADG Historical P/B Ratio — Book Value Per Share & Year-End Price
Kabra Drugs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.45 | ₹12.5 | ₹18.08 | ₹30 | Moderate |
| 2025 | 2.93 | ₹10.42 | ₹30.55 | ₹25 | Moderate |
| 2024 | 4.02 | ₹2.5 | ₹10.06 | ₹1 | High |
KABRADG vs Healthcare Peers — P/B Ratio Comparison
Kabra Drugs P/B 1.56 vs Healthcare average 0.01, median 0.61 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.19 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |